Insight Molecular Diagnostics Inc.
NASDAQ:IMDXMedical - Diagnostics & Research
Healthcare
$1.59 +2.44%
+$0.13 today
- Market cap
- $52.08M
- Beta
- 1.79
- P/E (TTM)
- -3.9
- EPS (TTM)
- -$1.39
52W Low $2.33High $8.51
Volume 0.64M
Average 0.38M
Price history
Insight Molecular Diagnostics Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-74.88%
Period high
$7.50
Period low
$1.59
Latest
$1.59
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Sep 21, 2026 | Sep 21, 2026 | |
| 10-Q | Aug 10, 2026 | Aug 10, 2026 | |
| 8-K | Aug 10, 2026 | Aug 10, 2026 | |
| S-8 | Jul 24, 2026 | Jul 24, 2026 | |
| 4 | Jul 6, 2026 | Jul 6, 2026 | |
| 4 | Jul 6, 2026 | Jul 6, 2026 | |
| 4 | Jul 6, 2026 | Jul 6, 2026 | |
| 8-K | Jun 17, 2026 | Jun 17, 2026 | |
| 4 | Jun 15, 2026 | Jun 15, 2026 | |
| 4 | Jun 15, 2026 | Jun 15, 2026 | |
| 4 | Jun 15, 2026 | Jun 15, 2026 | |
| 8-K | May 13, 2026 | May 13, 2026 | |
| 10-Q | May 13, 2026 | May 13, 2026 | |
| 8-K/A | May 13, 2026 | May 13, 2026 | |
| ARS | Apr 30, 2026 | Apr 30, 2026 |
Competitors
Who does Insight Molecular Diagnostics Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about IMDX's filings, answered from its disclosures.
What is the latest IMDX filing?
The latest filing shown is 8-K dated Sep 21, 2026.
How many recent filings does IMDX have?
Intrinsic Alpha currently shows 20 recent filings for IMDX.
Continue the stock analysis
Jump to another research area for this company.